2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Thyroid Neoplasms
3
Prostatic Neoplasms
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Synovial
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Liposarcoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tongue Neoplasms
1
Tobacco Use Disorder
1
Thyroid Nodule
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Salivary Gland Neoplasms
1
Interventions
Cisplatin
127
Gemcitabine
71
Radiotherapy, Intensity-Modulated
61
toripalimab
39
Capecitabine
37
Docetaxel
36
Fluorouracil
35
Radiotherapy
24
camrelizumab
23
Drug Therapy
22
nimotuzumab
18
spartalizumab
13
pembrolizumab
13
nedaplatin
12
Chemoradiotherapy
12
sintilimab
11
apatinib
11
Induction Chemotherapy
11
Immune Checkpoint Inhibitors
11
tislelizumab
10
Nivolumab
10
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Radiation
9
Cetuximab
9
Carboplatin
9
endostar protein
8
Paclitaxel
8
Bevacizumab
8
anlotinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Molecular Diagnostic Techniques
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled